Nkarta, Inc.
NASDAQ:NKTXBiotechnology
Healthcare
$1.12 +3.41%
+$0.09 today
- Market cap
- $80.22M
- Beta
- 0.90
- P/E (TTM)
- -2.0
- EPS (TTM)
- -$1.35
52W Low $1.63High $3.65
Volume 0.66M
Average 0.75M
Income Statement
Follow revenue through to earnings.
Revenue
$0.00
FY 2025 · Annual
Operating Income
-$121.21M
FY 2025 · Annual
Net Income
-$104.08M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 5.87M | 0 | 9.19M |
| Gross Profit | 0 | 0 | (5.87M) | 0 | (9.19M) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 63.41M | 90.9M | 90.9M | 96.74M | 90.43M |
| Selling, General & Admin | 23.02M | 28.06M | 34.88M | 31.45M | 31.57M |
| Operating Expenses | 86.43M | 118.96M | 125.78M | 128.19M | 112.01M |
| Depreciation & Amortization | 1.76M | 2.64M | 5.87M | 9.15M | 9.19M |
| EBITDA | (84.32M) | (105.61M) | (120.48M) | (99.64M) | (94.89M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (86.43M) | (118.96M) | (131.65M) | (128.19M) | (121.21M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 370K | 5.59M | 14.11M | 19.32M | 15.49M |
| Interest Expense | 0 | 5.59M | 0 | 0 | 0 |
| Other Income / Expenses | 354K | 5.12M | 14.15M | 19.4M | 17.12M |
| Income Before Tax | (86.08M) | (113.84M) | (117.5M) | (108.79M) | (104.08M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (86.08M) | (113.84M) | (117.5M) | (108.79M) | (104.08M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (2.62) | (2.61) | (2.40) | (1.60) | (1.41) |
| EPS (Diluted) | (2.62) | (2.61) | (2.40) | (1.60) | (1.41) |
| 32.86M | 43.63M | 49.01M | 67.87M | 73.99M | |
| 32.86M | 43.63M | 49.01M | 67.87M | 73.99M |
NKTX Earnings Waterfall · TTM
NASDAQ:NKTX · Revenue to Net Income
Key Ratios
EPS$-1.34
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-1.4
P/S Ratio0.0
Analysis
$0 of revenue converted into -$99.9M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.34, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 9, 2026 | |
| 8-K | Current report | Nov 6, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| 8-K | Current report | Nov 5, 2026 | |
| 8-K | Current report | Aug 10, 2026 |
How much revenue does NKTX generate?
Nkarta, Inc. (NKTX) reported $0.00 of revenue in fiscal 2025.
Is NKTX profitable?
Nkarta, Inc. (NKTX) reported -$104.08M of net income.
Continue the stock analysis
Jump to another research area for this company.